PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsOliceridine
Oliceridine
Olinvyk (oliceridine) is a small molecule pharmaceutical. Oliceridine was first approved as Olinvyk on 2020-10-30. It is used to treat acute pain in the USA.
Download report
Favorite
FDA Novel Drug Approvals 2020
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oliceridine
Tradename
Company
Number
Date
Products
OLINVYKTrevenaN-210730 DISCN2020-10-30
3 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
olinvykNew Drug Application2023-12-29
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
acute pain—D059787R52
Agency Specific
FDA
EMA
Expiration
Code
OLICERIDINE, OLINVYK, TREVENA
2025-10-30NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Oliceridine, Olinvyk, Trevena
88354882032-03-23DS, DPU-2986
93092342032-03-23DS, DPU-2986
96428422032-03-23DPU-2986
110770982032-03-23DS, DPU-2986
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AX: Other opioids in atc
— N02AX07: Oliceridine
HCPCS
Code
Description
C9101
Injection, oliceridine, 0.1 mg
Clinical
Clinical Trials
20 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute painD059787—R52113——5
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52—2———2
Bone fracturesD050723EFO_0003931T14.8—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———2————2
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOliceridine
INNoliceridine
Description
Oliceridine, sold under the brand name Olinvyk, is an opioid medication that is used for the treatment of moderate to severe acute pain in adults. It is given by intravenous (IV) injection.
Classification
Small molecule
Drug classanalgesics (meperidine type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1
Identifiers
PDB—
CAS-ID1401028-24-7
RxCUI—
ChEMBL IDCHEMBL2443262
ChEBI ID—
PubChem CID66553195
DrugBankDB14881
UNII IDMCN858TCP0 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 608 documents
View more details
Safety
Black-box Warning
Black-box warning for: Olinvyk
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use